Literature DB >> 9583726

Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.

S E Baldus1, T K Zirbes, S Engel, F G Hanisch, S P Mönig, J Lorenzen, J Glossmann, S Fromm, J Thiele, H Pichlmaier, H P Dienes.   

Abstract

The expression of MUC1 and MUC2 mucin peptide core antigens in gastric carcinomas was studied by immunohistochemistry to determine correlations with TNM stage and histo-pathological classifications as well as a possible prognostic impact. Paraffin-embedded specimens from 128 gastric carcinomas with a minimal follow-up of 5 years were immunostained. In addition to a polyclonal antiserum generated against polymorphic epithelial mucin (MUC1) from human milk, 2 monoclonal antibodies (MAbs), HMFG2 (anti-MUC1) and 4FI (anti-MUC2), were applied. Reactivity of carcinomas was correlated with the classifications of the UICC (TNM), WHO and Laurén. Correlations with overall survival were analyzed using the Kaplan and Meier product limit method. MUC1 immunoreactivity was associated with an advanced pTNM stage. The demonstration of both mucin species (MUC1, MUC2) displayed a statistically significant correlation with tubular/papillary vs. signet-ring cell differentiation as well as with intestinal-type vs. diffuse-type of tumor growth according to Laurén. In particular, MUC2 was only rarely detectable in signet-ring cell and diffuse-type tumors. MUC1 correlated with poor prognosis in all cases and the subgroup of stage I tumors. According to the histopathological classifications, a similar result was observed in signet-ring cell and diffuse-type carcinomas. In contrast, MUC2 reactivity was associated with a favourable prognosis of intestinal-type carcinomas. In the non-neoplastic gastric mucosa, both peptide cores were recognized in the superficial epithelium, whereas parietal cells contained only MUC1, and intestinal metaplasia almost exclusively MUC2 antigens. We conclude that the mucin peptide core antigens are suitable markers for the tubule-rich gastric carcinomas, which may in part be derived from intestinal metaplasia. In addition, MUC1 may exert a prognostic relevance and appears to be involved in the progression of diffuse-type tumors.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9583726     DOI: 10.1002/(sici)1097-0215(19980417)79:2<133::aid-ijc6>3.0.co;2-u

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

1.  Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool.

Authors:  P J Limburg; D A Ahlquist; J A Gilbert; J J Harrington; G G Klee; P C Roche
Journal:  Dig Dis Sci       Date:  2000-03       Impact factor: 3.199

2.  Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.

Authors:  Kristina Roessler; Stefan-P Mönig; Paul-M Schneider; Franz-Georg Hanisch; Stephanie Landsberg; Juergen Thiele; Arnulf-H Hölscher; Hans-P Dienes; Stephan-E Baldus
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

3.  MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma.

Authors:  Chanchai Boonla; Banchob Sripa; Peti Thuwajit; Ubon Cha-On; Anucha Puapairoj; Masanao Miwa; Sopit Wongkham
Journal:  World J Gastroenterol       Date:  2005-08-28       Impact factor: 5.742

4.  Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes.

Authors:  Koji Morohara; Yusuke Tajima; Kentaro Nakao; Nobukazu Nishino; Shigeo Aoki; Masanori Kato; Masaaki Sakamoto; Kimiyasu Yamazaki; Tsutomu Kaetsu; Satoshi Suzuki; Akira Tsunoda; Tetsuhiko Tachikawa; Mitsuo Kusano
Journal:  J Cancer Res Clin Oncol       Date:  2006-01-31       Impact factor: 4.553

5.  Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinico-pathological features and prognosis.

Authors:  Rodrigo Oliva Perez; Bárbara Helou Bresciani; Cláudio Bresciani; Igor Proscurshim; Desiderio Kiss; Joaquim Gama-Rodrigues; Diego Daniel Pereira; Viviane Rawet; Ivan Cecconnello; Angelita Habr-Gama
Journal:  Int J Colorectal Dis       Date:  2008-05-06       Impact factor: 2.571

6.  Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Authors:  Tsutomu Mizoshita; Tetsuya Tsukamoto; Hayao Nakanishi; Ken-ichi Inada; Naotaka Ogasawara; Takashi Joh; Makoto Itoh; Yoshitaka Yamamura; Masae Tatematsu
Journal:  J Cancer Res Clin Oncol       Date:  2003-10-14       Impact factor: 4.553

7.  Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Authors:  Edaise M Silva; Maria D Begnami; José Humberto T G Fregnani; Adriane G Pelosof; Claudia Zitron; André L Montagnini; Fernando Augusto Soares
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

8.  Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.

Authors:  Hong-Kai Zhang; Qiu-Min Zhang; Tie-Hua Zhao; Yuan-Yuan Li; Yong-Fen Yi
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

9.  MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.

Authors:  J Pinto-de-Sousa; C A Reis; L David; A Pimenta; M Cardoso-de-Oliveira
Journal:  Virchows Arch       Date:  2004-01-31       Impact factor: 4.064

10.  Prognostic significance of mucin expression in gastric carcinoma.

Authors:  Belma Kocer; Atilla Soran; Gulten Kiyak; Sibel Erdogan; Abdullah Eroglu; Betül Bozkurt; Cem Solak; Omer Cengiz
Journal:  Dig Dis Sci       Date:  2004-06       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.